Immunotherapy and Radiotherapy as an Antitumoral Long-Range Weapon—A Partnership with Unsolved Challenges: Dose, Fractionation, Volumes, Therapeutic Sequence

Immunotherapy, the modern oncological treatment with immune checkpoint inhibitors (ICIs), has been part of the clinical practice for malignant melanoma for more than a decade. Anti-cytotoxic T-lymphocyte antigen 4 (CTLA4), anti-programmed cell death Protein 1 (PD-1), or anti programmed death-ligand...

Descripción completa

Detalles Bibliográficos
Autores principales: Mireștean, Camil Ciprian, Iancu, Roxana Irina, Iancu, Dragoș Teodor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601214/
https://www.ncbi.nlm.nih.gov/pubmed/36290857
http://dx.doi.org/10.3390/curroncol29100580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601214/
https://www.ncbi.nlm.nih.gov/pubmed/36290857
http://dx.doi.org/10.3390/curroncol29100580

Ejemplares similares